1. <dd id="jhdwb"><source id="jhdwb"></source></dd>

    <small id="jhdwb"></small>
    1. <strong id="jhdwb"></strong>
      <mark id="jhdwb"></mark>
    2. 產(chǎn)品資料

      Recombinant Human IL-1RA|重組人白介素-1受體拮抗劑

      產(chǎn)品名稱(chēng): Recombinant Human IL-1RA|重組人白介素-1受體拮抗劑
      產(chǎn)品型號: C22-101-01C
      產(chǎn)品展商: PERFEMIKER
      產(chǎn)品文檔: 無(wú)相關(guān)文檔

      簡(jiǎn)單介紹

      Recombinant Human IL-1RA|重組人白介素-1受體拮抗劑 現貨促銷(xiāo),>95% by SDS-PAGE and HPLC analyses.


      Recombinant Human IL-1RA|重組人白介素-1受體拮抗劑  的詳細介紹

      產(chǎn)品名稱(chēng):Recombinant Human IL-1RA|重組人白介素-1受體拮抗劑

      單   位:

      Recombinant Human IL-1RA|重組人白介素-1受體拮抗劑,國產(chǎn)細胞因子,cytokine


      產(chǎn)品詳細介紹:
      C22-101-01C   2μg/¥500   10μg/¥1000   1mg/詢(xún)價(jià)
       
      Purity:
      >95% by SDS-PAGE and HPLC analyses.

      Biological Activity:
      Fully biologically active when compared to standard. The ED50 as determined by the dose-dependant inhibition of IL-1 stimulation of D10S cells was found to be 0.5 ng/ml, corresponding to a Specific Activity of 2.0 x 106 IU/mg.

      Storage:
      This lyophilized preparation is stable at 2-8°C, but should be kept at -20°C for long term storage, preferably desiccated. Upon reconstitution, the preparation is stable for up to one week at 2-8°C. For maximal stability, apportion the reconstituted preparation into working aliquots and store at -20°C to -70°C. Avoid repeated freeze/thaw cycles.

      Copyright@ 2003-2024  上海創(chuàng )賽科技有限公司版權所有     

      國內免費服務(wù)專(zhuān)線(xiàn):400 608 7598(據說(shuō)天才可以在15秒內記住我們的免費電話(huà)哦^_^)

      服務(wù)升級,全新企業(yè)QQ為您服務(wù),企業(yè)QQ號:4006087598

      創(chuàng )賽官網(wǎng)升級為創(chuàng )賽優(yōu)選商城,請移步www.canspec.cn注冊登錄,新用戶(hù)注冊送1000元現金券

               滬ICP備09040904號-1     

      滬公網(wǎng)安備 31011402005168號

      欧美精品专区高清在线爱美_香蕉久久一区二区不卡无毒影院_亚洲精品国产福利在线观看_久久AV无码精品人妻系列果冻
      1. <dd id="jhdwb"><source id="jhdwb"></source></dd>

        <small id="jhdwb"></small>
        1. <strong id="jhdwb"></strong>
          <mark id="jhdwb"></mark>